A Randomized Multicenter Study for Isolated Skin Vasculitis (ARAMIS)

Brief description of study

The purpose of this study is to evaluate different treatment options for patients with skin vasculitis (also named cutaneous vasculitis). Patients with isolated cutaneous small vessel vasculitis, medium-sized vessel vasculitis (polyarteritis nodosa), or IgA vasculitis (Henoch-Schönlein purpura) can join this study. The frequently used treatments for skin vasculitis are colchicine, dapsone and azathioprine. Eligible patients will initially be randomized to receive one of the 3 medications under investigation for 6 months (stage 1). Subjects may remain on the drug for stage 2, or they may be randomized to one of the remaining drugs. The study will compare how effective these drugs are at treating isolated cutaneous vasculitis.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
['Primary Cutaneous Vasculitis', 'Cutaneous Polyarteritis Nodosa', 'IgA Vasculitis', 'Henoch-Schönlein Purpura']
Age: - 99 Years
Gender: All

Updated on 09 Mar 2024. Study ID: 825128

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).